Drug Type Degradable Molecular Glue |
Synonyms MRANK 002, MRANK-002, MRANK002 |
Target |
Action degraders |
Mechanism c-Myc degraders(Myc proto-oncogene protein degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | China | 31 Jul 2024 | |
Non-Small Cell Lung Cancer | Preclinical | China | 31 Jul 2024 | |
Small Cell Lung Cancer | Preclinical | China | 31 Jul 2024 |